President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits on what the government will pay.

According to the timeline laid out in President Donald Trump’s May 12 executive order, prescription drug price reductions would not happen "almost immediately." The order specifies a 30-day period to develop pricing targets for drugmakers,

President Trump will hold a press conference Monday morning with Health and Human Services Secretary Robert F. Kennedy Jr. to announce an executive order to cap prescription drug and pharmaceutical prices at the lowest cost offered in any other country.

The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

The editorial board of the Wall Street Journal is criticizing President Trump over an executive order expanding drug price controls. “For that trade we could have elected Democrats,”